Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Dr Stoten will be taking over from retiring Managing Director Linda Naylor from April.

Oxford University Innovation (OUI), the research commercialisation company of Oxford University, has named its new Chief Operating Officer (COO). Dr Adam Stoten, the current Head of Technology Transfer Life Sciences at OUI, will be taking up the newly-created position from 1st April 2017.

Stoten, who holds a PhD in Immunology from the University of Nottingham, has been a leading figure at OUI since 2005 when he joined the company as a Project Manager. In 2010, he joined the Oxford-Emergent Tuberculosis Consortium, a joint venture between Oxford University and Emergent BioSolutions, which conducted the first ever efficacy study of a new tuberculosis vaccine in infants. He remained with the spinout until 2013 as its Deputy General Manager, before returning to OUI to head up its life sciences commercialisation activities.

Read more (Oxford University Innovation website)

Similar stories

Research programme tackling COVID-19 variants of concern receives funding boost

A gift from the Red Avenue Foundation will enable the expansion of a major research programme aimed at rapidly identifying and interrogating emerging COVID-19 variants.

Oxford overseas research facility expands to include diagnostics and genetics testing centre

The Oxford-Suzhou Centre for Advanced Research, known as OSCAR, has marked another significant milestone with the launch of OSCAR-Prenetics Innovation and Technology Centre for Advanced Molecular Diagnostics (the OSCAR-Prenetics ITC).

Tanmay Bharat Awarded Lister Institute Research Prize

Tanmay Bharat, a group leader at the Sir William Dunn School of Pathology, has been awarded a prestigious Lister Institute Research Prize in the 2021 funding round.

£24m investment into adolescent mental health to enable young people to flourish

UKRI have announced a major £24 million investment into improving the mental health and wellbeing of adolescents in the UK. One of the projects being funded is led by Professor Kam Bhui in the Department of Psychiatry, it will bring together diverse creative-arts, digital and health experts to investigate how adverse childhood experiences (ACEs) can affect adolescents' mental health.

Dr Lennard Lee awarded ACP McElwain Prize for contributions to medical oncology

Dr Lee (Department of Oncology) received the award to acknowledge his contributions during the COVID-19 pandemic, through the establishment of the UK Coronavirus Cancer Monitoring Project.

Oxford joins forces with 11 universities to launch social impact investment fund

The University of Oxford has joined forces with 11 leading universities to create Impact 12, an impact investment fund to support mission-led university ventures.